ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.471,40
0,20%
Brent Oil
79,395
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sonus Pharmaceuticals (MM) (SNUS)

  7. Sonus Pharmaceuticals (MM) (SNUS) Notícias

SNUS

Sonus (SNUS)

Sonus Pharmaceuticals (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNUS
DataHoraFonteTítuloCódigoCompanhia
21/08/200810:42PR Newswire (US)Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading onNASDAQ:SNUS
07/08/200817:41Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:SNUSSonus Pharmaceuticals (MM)
05/08/200818:02Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:SNUSSonus Pharmaceuticals (MM)
21/07/200807:01Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
17/07/200816:10PR Newswire (US)Sonus Pharmaceuticals Receives Favorable NASDAQ DecisionNASDAQ:SNUSSonus Pharmaceuticals (MM)
03/07/200817:21Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
30/05/200812:37Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
30/05/200807:30Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
28/05/200808:35PR Newswire (US)Sonus Pharmaceuticals and OncoGenex Technologies to MergeNASDAQ:SNUSSonus Pharmaceuticals (MM)
29/04/200817:36Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Amended Annual Report (10-K/A)NASDAQ:SNUSSonus Pharmaceuticals (MM)
20/03/200818:57Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:SNUSSonus Pharmaceuticals (MM)
14/03/200818:02Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:SNUSSonus Pharmaceuticals (MM)
13/02/200812:43Edgar (US Regulatory)Sonus Pharmaceuticals Inc - Statement of Ownership (SC 13G)NASDAQ:SNUSSonus Pharmaceuticals (MM)
24/09/200714:41Edgar (US Regulatory)Sonus Pharmaceuticals Inc (Other) (8-K)NASDAQ:SNUSSonus Pharmaceuticals (MM)
03/08/200712:00Business WireSonus Pharmaceuticals Highlights Corporate Progress and Reports Second Quarter Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
19/07/200718:30Business WireSonus Pharmaceuticals to Release Second Quarter Financial Results and Hold Quarterly Conference Call on August 3NASDAQ:SNUSSonus Pharmaceuticals (MM)
13/06/200709:30Business WireSonus Pharmaceuticals Awarded Patent for TOCOSOL(R) Camptothecin, the Company's Second Oncology Product CandidateNASDAQ:SNUSSonus Pharmaceuticals (MM)
04/06/200717:30Business WireSonus Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:SNUSSonus Pharmaceuticals (MM)
09/05/200717:15Business WireSonus Pharmaceuticals Highlights Progress and Reports First Quarter Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
07/05/200720:39Business WireSonus Pharmaceuticals to Present at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare ConferenceNASDAQ:SNUSSonus Pharmaceuticals (MM)
03/05/200720:04Business WireSonus Pharmaceuticals to Release First Quarter Financial Results and Hold Conference Call on May 9NASDAQ:SNUSSonus Pharmaceuticals (MM)
19/03/200719:39Business WireSonus Pharmaceuticals to Present at WBBA Invest Northwest(TM)NASDAQ:SNUSSonus Pharmaceuticals (MM)
14/03/200717:15Business WireSonus Pharmaceuticals Reviews Key Achievements in 2006 and Reports Fourth Quarter and Full Year Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
07/03/200720:20Business WireSonus Pharmaceuticals to Release Fourth Quarter and Full Year 2006 Financial Results and Hold Year-end Conference Call on MarchNASDAQ:SNUSSonus Pharmaceuticals (MM)
07/12/200620:30Business WireSonus Pharmaceuticals to Participate in RBC Capital Markets Healthcare Conference, December 13NASDAQ:SNUSSonus Pharmaceuticals (MM)
21/11/200620:30Business WireSonus Pharmaceuticals to Present at Lazard Capital Markets Third Annual Life Sciences Conference, November 29NASDAQ:SNUSSonus Pharmaceuticals (MM)
16/11/200611:30Business WireSonus Pharmaceuticals Announces Completion of Patient Enrollment in Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel in MetastaticNASDAQ:SNUSSonus Pharmaceuticals (MM)
08/11/200619:07Business WireSonus Pharmaceuticals Updates Corporate Progress and Reports Third Quarter Financial ResultsNASDAQ:SNUSSonus Pharmaceuticals (MM)
31/10/200618:30Business WireSonus Pharmaceuticals to Release Third Quarter Financial Results and Hold Quarterly Conference Call November 8NASDAQ:SNUSSonus Pharmaceuticals (MM)
28/09/200609:30Business WireSonus Pharmaceuticals Initiates Phase 1 Clinical Trial for Company's Second Anti-cancer Drug, TOCOSOL(R) CamptothecinNASDAQ:SNUSSonus Pharmaceuticals (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNUS

Seu Histórico Recente

COIN
HPLUST
HappyLand.Finance
USOTC
OIIIF
O3 Mining (QX)
BIT
P1SVI2
BNP Paribas Issuance
COIN
MCAUSD
MECA Coin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados